Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107784752 | 10778475 | 2 | F | 2012 | 20160721 | 20150210 | 20160726 | EXP | BR-AMGEN-BRASP2012036631 | AMGEN | 26.00 | YR | A | F | Y | 64.00000 | KG | 20160726 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107784752 | 10778475 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, ONCE WEEKLY | J13794 | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | |||||
| 107784752 | 10778475 | 2 | C | FAMOTIDINE. | FAMOTIDINE | 1 | 20 MG, AT LUNCH AND AT DINNER | 0 | 20 | MG | CAPSULE | BID | |||||||
| 107784752 | 10778475 | 3 | C | TENOXICAM | TENOXICAM | 1 | ONE CAPSULE (10 MG), DAILY (AT DINNER) | 0 | 10 | MG | CAPSULE | ||||||||
| 107784752 | 10778475 | 4 | C | CHLOROQUINE DIPHOSPHATE | CHLOROQUINE PHOSPHATE | 1 | ONE CAPSULE (250 MG), DAILY (AT DINNER) | 0 | 250 | MG | |||||||||
| 107784752 | 10778475 | 5 | C | PREDNISONE. | PREDNISONE | 1 | 2 MG, UNK | 0 | 2 | MG | |||||||||
| 107784752 | 10778475 | 6 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 3 MG, DAILY, AT BEDTIME | 0 | 3 | MG | |||||||||
| 107784752 | 10778475 | 7 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | UNK | 0 | |||||||||||
| 107784752 | 10778475 | 8 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 107784752 | 10778475 | 9 | C | DIPIRONA | METAMIZOLE | 1 | 350 MG, DAILY (AT BEDTIME) | 0 | 350 | MG | |||||||||
| 107784752 | 10778475 | 10 | C | METHOTREXATE. | METHOTREXATE | 1 | 4 UNITS (UNSPECIFIED DOSE) AT SATURDAY | 0 | 4 | DF | /wk | ||||||||
| 107784752 | 10778475 | 11 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | UNK | 0 | |||||||||||
| 107784752 | 10778475 | 12 | C | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | 10 MG, DAILY, AT BEDTIME | 0 | 10 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107784752 | 10778475 | 1 | Rheumatoid arthritis |
| 107784752 | 10778475 | 10 | Rheumatoid arthritis |
| 107784752 | 10778475 | 11 | Gastric disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 107784752 | 10778475 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107784752 | 10778475 | Crohn's disease | |
| 107784752 | 10778475 | Decreased immune responsiveness | |
| 107784752 | 10778475 | Injection site erythema | |
| 107784752 | 10778475 | Injection site induration | |
| 107784752 | 10778475 | Injection site pain | |
| 107784752 | 10778475 | Injection site pruritus | |
| 107784752 | 10778475 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107784752 | 10778475 | 1 | 20120517 | 0 | ||
| 107784752 | 10778475 | 10 | 2010 | 0 | ||
| 107784752 | 10778475 | 11 | 2014 | 0 |